Other (pressing)
Full-time
Salary
150,000 - 210,000 USD per year
Routes to impact
Direct high impact on an important cause
Description
Own end-to-end analysis of in vivo Perturb-seq data across cardio-renal-metabolic programs, turning large-scale single-cell screens into prioritized biological hypotheses.
- Analyze single-cell transcriptomic data from raw QC through hit calling and validation planning
- Partner with disease leads across heart, kidney, adipose, and liver programs
- Improve analysis methods using multimodal integration, benchmarking, and emerging foundation-model approaches
- Define controls, assess predictive power, and guide forward screen planning across concurrent projects
This text was generated by AI. If you notice any inconsistencies, please let us know using this form.



